Showing results (251-260 of 375) with videos related to

Sort By:
Pageof 38
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 26, 2015
Shedding light on minipig drug metabolism - elevated amide hydrolysis in vitroRussell Jones, Michaela Marschmann, Michael Keller, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 9, 2000
Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patientsN C Jackson, P V Carroll, D L Russell-Jones, et al.
The American Journal of Physiology|January 14, 1999
The metabolic consequences of critical illness: acute effects on glutamine and protein metabolismN C Jackson, P V Carroll, D L Russell-Jones, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 7, 2012
Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemiaR Herring, D L Russell-Jones, C Pengilley, et al.
The Quarterly Journal of Medicine|July 1, 1989
Vasculitis complicating cystic fibrosisM J Finnegan, J Hinchcliffe, D Russell-Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletesM L Healy, J Gibney, D L Russell-Jones, et al.
Clinical Endocrinology|September 1, 1999
Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled studyE R Christ, M H Cummings, P J Lumb, et al.
The British Journal of Dermatology|September 5, 2002
Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoidesX Mao, D Lillington, J J Scarisbrick, et al.
Clinical Endocrinology|September 1, 1994
The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patientsD L Russell-Jones, G F Watts, A Weissberger, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
Pageof 38